Ingredient or product comparison
Comparison: GHK-Cu Research Timeline vs Other Peptides
GHK-Cu 24–72 hours (collagen mRNA upregulation) 4–8 weeks (dermal thickness, wrinkle reduction) Integrin receptor binding → MAPK/TGF-β signaling → collagen synthesis + MMP inhibition Robust evidence base, dose-dependent response, requires sustained exposure fo
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu
- 24–72 hours (collagen mRNA upregulation)
- 4–8 weeks (dermal thickness, wrinkle reduction)
- Integrin receptor binding → MAPK/TGF-β signaling → collagen synthesis + MMP inhibition
- Robust evidence base, dose-dependent response, requires sustained exposure for structural outcomes
- Palmitoyl Pentapeptide-4 (Matrixyl)
- 48–96 hours (procollagen synthesis)
- 6–12 weeks (wrinkle depth reduction)
- TGF-β pathway activation → collagen I/III synthesis
- Slower onset than GHK-Cu, primarily collagen-focused (no MMP modulation)
- Acetyl Hexapeptide-8 (Argireline)
- 2–4 hours (muscle contraction inhibition)
- 2–4 weeks (expression line softening)
- SNARE complex disruption → reduced neurotransmitter release
- Fastest visible onset, but mechanism is neuromuscular, not structural remodeling
- Copper Peptide (non-GHK)
- 72–120 hours (angiogenesis markers)
- 8–12 weeks (wound closure acceleration)
- VEGF upregulation → neovascularization
- Longer timeline, mechanism differs from GHK-Cu's direct collagen synthesis effect